| Johann Lukas Schoenlein Award 2002 | p. XXXI |
| Epidemiology | |
| HIV Infection and Causes of Death in Patients with Hemophilia in Germany (Year 2001/2002 Survey) | p. 3 |
| Hemophilia Registry of the Medical Committee of the Swiss Hemophilia Association - Annual Survey 2002 | p. 13 |
| ”New Viruses“ and the Safety of Factor Concentrates and Stable Blood Products: TT Virus and West Nile Virus as Current Examples | p. 19 |
| New Findings and Possibilities in Therapy of Antibodies | |
| A Retrospective Study on the Development of Inhibitors after Continuous Infusion of Factor VIII | p. 23 |
| Characterization of Factor VIII-Inhibitory Antibodies Using Phage Display | p. 27 |
| Rituximab - A new Treatment of Acquired Hemophilia A? | p. 35 |
| Thrombin Generation and Thrombogram: Assays for Monitoring Factor VIII Bypassing Therapies | p. 38 |
| Hemophilia: Therapeutic Exercise and Sport | |
| Rehabilitation - A Topic for Hemophiliacs? | p. 51 |
| Functional Analysis as a Basis for Optimizing Physiotherapy in Hemophilic Children | p. 57 |
| Sport and Physical Fitness Recommendations for Young Hemophiliacs | p. 66 |
| Pain Versus Clinical and Radiological Assessment in Hemophilic Arthropathies | p. 74 |
| Laboratory Diagnostics | |
| Endogenous Thrombin Potential in Platelet-Rich Plasma - New Insights Regarding the Different Action of F VIII and F IX | p. 87 |
| Pediatric Hemostaseoloy | |
| Interactive and Case-Based Training of Diagnostic Skills and Therapeutical Management of Coagulation Disorders with CAMPUS, a Computer-Based Program | p. 97 |
| Elevated Fibrinogen is a Risk Factor for Arterial Thrombosis in Children | p. 101 |
| Increased von-Willebrand-Factor-Binding to Platelets in Neonatal Plasma | p. 106 |
| Neonatal Protein C Deficiency after massive thromboembolic Event of the right upper Limb Treatment with Protein C Concentrate | p. 110 |
| Free Lectures | |
| IMMUNATE S/D - A new Factor VIII - von-Willebrand-Factor Complex Concentrate | p. 117 |
| Favorable Response to Protein C in Venoocclusive Disease after Allogeneous Stem Cell Transplantation | p. 135 |
| Phase III Clinical Evaluation of rAHF-PFM Prepared Using a Plasma/Albumin free Method | p. 143 |
| Anti-Prionin IgG, Possible new Serum Markers for Contact and Infection with Transmissible Spongiform Encephalopathies: Preliminary Results from Screening 100 Blood Donors | p. 150 |
| Experimental Approaches to Hemophilia Gene Therapy: Gene Transfer into Hematopoietic Stem Cells | p. 153 |
| Von-Willebrand-Factor Cleaving Protease (ADAMTS-13) Activity in Various Thrombotic, Hemolytic and Autoimmune Disorders | p. 159 |
| Poster | |
| Clinic and Casuistic | |
| Treatment with Interferon Alpha-2a in Patients with Hepatitis C and Hemophilia | p. 167 |
| Practical Experiences with Therapies for Chronic Hepatitis C in Hemophilia Patients | p. 173 |
| Deep Venous Thrombosis of the Lower Extremity in a 16-Year-old Girl with Homozygous MTHFR- and Heterozygous Factor V Leiden-Mutation | p. 176 |
| Clinical Manifestations of Patients with Highly Elevated Anticardiolipin Antibodies | p. 179 |
| Progression of an Extensive Deep Vein Thrombosis Under High Dose Therapy with low Molecular Weight Heparin of a 13-4 Year-old Girl Suffering from Colitis Ulcerosa | p. 185 |
| Hyperfibrinolysis in Hemophagocytic Lymphohistiocytosis | p. 187 |
| Prolonged Lysis-Therapy of an Arteria Iliaca Externa Thrombosis in a very low Birth Weight Infant with a Variant in the Factor-XIII-Gene | p. 192 |
| Modified Immunsuppression in a Case of Acquired Hemophilia -Case Report | p. 196 |
| Life-Threatening Bleeding after Vaccination as a First Manifestation of Hemophilia A | p. 199 |
| Administration of Protein C-Concentrate (Ceprotin, Baxter) in Purpura Fulminans as the First Clinical Manifestation of Galactosemia | p. 201 |
| Case Report: Successful Treatment of a Spontaneous Acquired Inhibitor against Factor VIII in a 73-Year old Patient | p. 205 |
| Hemophilia and hemorrhagic Disorders | |
| Medical Need and Quality of Life in Patients with Hemophilia A | p. 211 |
| Quality of Life Autoevaluation of Hemophilia Patients in Romania | p. 216 |
| Valproate-Induced Type I von-Willebrand's Disease - a Common Occurrence? | p. 222 |
| Bleeding Symptoms in Carriers of Hemophilia A - Association to the Factor VIII Gene Mutation? | p. 228 |
| Recombinant Human Interferon ¿-2b Therapy, for Refractory Immune Thrombocytopenic Purpura in Children | p. 232 |
| Review on Bleeding Episodes in Hemophiliacs Receiving no Primary Prophylactic Replacement Therapy | p. 237 |
| Endogenous Thrombin Potential and Thrombin Activatable Fibrinolysis Inhibitor in Patients with Hemophilia and von-Willebrand Disease | p. 250 |
| Thrombophilic Disorders | |
| Different Thrombotic Risk Factors - Contribution to the Endogenous Thrombin Potential | p. 257 |
| Coagulation Parameters in Pregnancy: Low-Molecular-Weight Heparin Prophylaxis in Women with Thrombophilic Risk Factors | p. 262 |
| Miscellaneous | |
| Malignancy is not Associated with Decreased ADAMTS-13 Activity in Patients with Brain Tumors | p. 269 |
| Analysis of Factor VIII RNA from Hemophilia A Patients with no Detectable Mutation in the Coding Regions | p. 276 |
| FISH for Carrier Detection of Large Deletions in the Factor VIII Gene | p. 279 |
| Homozygosity Mapping of a Second Gene Locus for Hereditary Combined Deficiency of Vitamin-K-Dependent Clotting Factors (FMFD) to Chromosome 16 | p. 282 |
| First Case of Compound Heterozygosity in the Gamma-Glutamyl Carboxylase Gene Causing Combined Deficiency of all Vitamin-K-Dependent Blood Coagulation Factors | p. 287 |
| Phosphatidylserine in the Neonatal and Adult Platelet Membrane: A Comparison | p. 291 |
| Low Protein C, Tissue Factor Pathway Inhibitor, and Antithrombin Allow Sufficient Thrombin Generation in Neonatal Plasma | p. 297 |
| Subject Index | p. 303 |
| Table of Contents provided by Publisher. All Rights Reserved. |
